These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 34440785)

  • 21. Keratin Hydrogel Enhances In Vivo Skeletal Muscle Function in a Rat Model of Volumetric Muscle Loss.
    Passipieri JA; Baker HB; Siriwardane M; Ellenburg MD; Vadhavkar M; Saul JM; Tomblyn S; Burnett L; Christ GJ
    Tissue Eng Part A; 2017 Jun; 23(11-12):556-571. PubMed ID: 28169594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volumetric Muscle Loss: A Bibliometric Analysis of a Decade of Progress.
    Kulwatno J; Goldman SM; Dearth CL
    Tissue Eng Part B Rev; 2023 Jun; 29(3):299-309. PubMed ID: 36475848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil and natural killer cell imbalances prevent muscle stem cell-mediated regeneration following murine volumetric muscle loss.
    Larouche JA; Fraczek PM; Kurpiers SJ; Yang BA; Davis C; Castor-Macias JA; Sabin K; Anderson S; Harrer J; Hall M; Brooks SV; Jang YC; Willett N; Shea LD; Aguilar CA
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2111445119. PubMed ID: 35377804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regenerative medicine for skeletal muscle loss: a review of current tissue engineering approaches.
    Langridge B; Griffin M; Butler PE
    J Mater Sci Mater Med; 2021 Jan; 32(1):15. PubMed ID: 33475855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laminin-111-Enriched Fibrin Hydrogels Enhance Functional Muscle Regeneration Following Trauma.
    Ziemkiewicz N; Hilliard GM; Dunn AJ; Madsen J; Haas G; Au J; Genovese PC; Chauvin HM; West C; Paoli A; Garg K
    Tissue Eng Part A; 2022 Apr; 28(7-8):297-311. PubMed ID: 34409846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiling of skeletal muscle after volumetric muscle loss.
    Nuutila K; Sakthivel D; Kruse C; Tran P; Giatsidis G; Sinha I
    Wound Repair Regen; 2017 May; 25(3):408-413. PubMed ID: 28494512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological Mitigation of Fibrosis in a Porcine Model of Volumetric Muscle Loss Injury.
    Corona BT; Rivera JC; Dalske KA; Wenke JC; Greising SM
    Tissue Eng Part A; 2020 Jun; 26(11-12):636-646. PubMed ID: 31856683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical Agents for Contractile-Metabolic Dysfunction After Volumetric Muscle Loss.
    McFaline-Figueroa J; Schifino AG; Nichenko AS; Lord MN; Hunda ET; Winders EA; Noble EE; Greising SM; Call JA
    Tissue Eng Part A; 2022 Sep; 28(17-18):795-806. PubMed ID: 35620911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An acellular biologic scaffold does not regenerate appreciable de novo muscle tissue in rat models of volumetric muscle loss injury.
    Aurora A; Roe JL; Corona BT; Walters TJ
    Biomaterials; 2015 Oct; 67():393-407. PubMed ID: 26256250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of devitalized muscle scaffolds is insufficient for appreciable de novo muscle fiber regeneration after volumetric muscle loss injury.
    Garg K; Ward CL; Rathbone CR; Corona BT
    Cell Tissue Res; 2014 Dec; 358(3):857-73. PubMed ID: 25300647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further development of a tissue engineered muscle repair construct in vitro for enhanced functional recovery following implantation in vivo in a murine model of volumetric muscle loss injury.
    Corona BT; Machingal MA; Criswell T; Vadhavkar M; Dannahower AC; Bergman C; Zhao W; Christ GJ
    Tissue Eng Part A; 2012 Jun; 18(11-12):1213-28. PubMed ID: 22439962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repairing Volumetric Muscle Loss with Commercially Available Hydrogels in an Ovine Model.
    Su EY; Kennedy CS; Vega-Soto EE; Pallas BD; Lukpat SN; Hwang DH; Bosek DW; Forester CE; Loebel C; Larkin LM
    Tissue Eng Part A; 2024 May; 30(9-10):440-453. PubMed ID: 38117140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying dysregulated immune cell subsets following volumetric muscle loss with pseudo-time trajectories.
    Hymel LA; Anderson SE; Turner TC; York WY; Zhang H; Liversage AR; Lim HS; Qiu P; Mortensen LJ; Jang YC; Willett NJ; Botchwey EA
    Commun Biol; 2023 Jul; 6(1):749. PubMed ID: 37468760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scalable macroporous hydrogels enhance stem cell treatment of volumetric muscle loss.
    Eugenis I; Wu D; Hu C; Chiang G; Huang NF; Rando TA
    Biomaterials; 2022 Nov; 290():121818. PubMed ID: 36209578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue Engineered 3D Constructs for Volumetric Muscle Loss.
    Gahlawat S; Oruc D; Paul N; Ragheb M; Patel S; Fasasi O; Sharma P; Shreiber DI; Freeman JW
    Ann Biomed Eng; 2024 Sep; 52(9):2325-2347. PubMed ID: 39085677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular matrix scaffolds for treatment of large volume muscle injuries: A review.
    Sarrafian TL; Bodine SC; Murphy B; Grayson JK; Stover SM
    Vet Surg; 2018 May; 47(4):524-535. PubMed ID: 29603757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal Muscle Tissue Engineering: Biomaterials-Based Strategies for the Treatment of Volumetric Muscle Loss.
    Carnes ME; Pins GD
    Bioengineering (Basel); 2020 Jul; 7(3):. PubMed ID: 32751847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Strategies for the Regeneration of Skeletal Muscle Tissue.
    Alarcin E; Bal-Öztürk A; Avci H; Ghorbanpoor H; Dogan Guzel F; Akpek A; Yesiltas G; Canak-Ipek T; Avci-Adali M
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptomic, Proteomic, and Morphologic Characterization of Healing in Volumetric Muscle Loss.
    Crum RJ; Johnson SA; Jiang P; Jui JH; Zamora R; Cortes D; Kulkarni M; Prabahar A; Bolin J; Gann E; Elster E; Schobel SA; Larie D; Cockrell C; An G; Brown B; Hauskrecht M; Vodovotz Y; Badylak SF
    Tissue Eng Part A; 2022 Dec; 28(23-24):941-957. PubMed ID: 36039923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rodent Model of Masseter Volumetric Muscle Loss for Studying Bioengineering Materials.
    Rohrer L; Striedinger K; Pomerantz J
    J Vis Exp; 2024 May; (207):. PubMed ID: 38884461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.